Adherium has introduced the SmartTurbo Model 4 monitoring device for the Turbuhaler DPI. The new device includes design improvements for older patients including easier installation and removal of the inhaler and larger buttons. According to Adherium, the SmartTurbo Model 4 also has added sensors to improve feedback on correct use of the Turbuhaler.
The company has been partnered with AstraZeneca to provide monitoring devices for AstraZeneca inhalers since 2015. Adherium’s SmartTouch sensor for AstraZeneca’s Symbicort MDI received 510(k) clearance from the FDA earlier this month.
Adherium CEO Arik Anderson commented, “We believe that SmartTurbo Model 4 will address a key unmet need for patients with asthma or chronic obstructive pulmonary disease by monitoring and improving adherence to their medications. We are now demonstrating the ability to design, obtain regulatory approvals, transfer to production, and release to market, on an annual cycle – improving the device with each successive generation.”
Read the Adherium press release.